Cargando…
A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix
Intracavitary brachytherapy (ICBT) and interstitial brachytherapy (IB) techniques are commonly practiced for treating carcinoma of the cervix, either alone or in combination with external beam radiotherapy. Both these brachytherapy techniques have their own advantages and limitations in terms of tum...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711042/ https://www.ncbi.nlm.nih.gov/pubmed/24892331 http://dx.doi.org/10.1120/jacmp.v15i3.4509 |
_version_ | 1783282995519553536 |
---|---|
author | Bansal, Anil K. Semwal, Manoj K. Sharma, Daya N. Thulkar, Sanjay Julka, Pramod K. Rath, Goura K. |
author_facet | Bansal, Anil K. Semwal, Manoj K. Sharma, Daya N. Thulkar, Sanjay Julka, Pramod K. Rath, Goura K. |
author_sort | Bansal, Anil K. |
collection | PubMed |
description | Intracavitary brachytherapy (ICBT) and interstitial brachytherapy (IB) techniques are commonly practiced for treating carcinoma of the cervix, either alone or in combination with external beam radiotherapy. Both these brachytherapy techniques have their own advantages and limitations in terms of tumor coverage and normal tissue sparing. Limited studies have been reported comparing the dosimetric features of these two techniques, especially from a single institution. We carried out a prospective clinical dosimetric comparison between ICBT and IB for patients treated at one center to bring out the inherent dosimetric features of these to two techniques. The study was carried out on 26 patients treated with ICBT and 55 with IB using CT‐based planning. Of the 55 patients treated with IB, 27 included tandem source loading (IBT) and 28 without the tandem loading (IBWT). The high‐dose volumes covered by 200% and 180% isodose surfaces were considerably larger in ICBT as compared to IB, whereas the treated volume was larger in IB as compared to ICBT. The bladder and rectal doses were the highest in ICBT and IBWT, respectively. The larger treated volume in IB as compared to ICBT was mainly because patients with larger tumor volumes were generally considered for IB. The results also indicated that in interstitial brachytherapy, better rectal sparing was achieved by including the tandem for treatment delivery. PACS numbers: 87.53.Bn, 87.53.Jw, 87.55.D‐, 87.55.dk |
format | Online Article Text |
id | pubmed-5711042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57110422018-04-02 A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix Bansal, Anil K. Semwal, Manoj K. Sharma, Daya N. Thulkar, Sanjay Julka, Pramod K. Rath, Goura K. J Appl Clin Med Phys Radiation Oncology Physics Intracavitary brachytherapy (ICBT) and interstitial brachytherapy (IB) techniques are commonly practiced for treating carcinoma of the cervix, either alone or in combination with external beam radiotherapy. Both these brachytherapy techniques have their own advantages and limitations in terms of tumor coverage and normal tissue sparing. Limited studies have been reported comparing the dosimetric features of these two techniques, especially from a single institution. We carried out a prospective clinical dosimetric comparison between ICBT and IB for patients treated at one center to bring out the inherent dosimetric features of these to two techniques. The study was carried out on 26 patients treated with ICBT and 55 with IB using CT‐based planning. Of the 55 patients treated with IB, 27 included tandem source loading (IBT) and 28 without the tandem loading (IBWT). The high‐dose volumes covered by 200% and 180% isodose surfaces were considerably larger in ICBT as compared to IB, whereas the treated volume was larger in IB as compared to ICBT. The bladder and rectal doses were the highest in ICBT and IBWT, respectively. The larger treated volume in IB as compared to ICBT was mainly because patients with larger tumor volumes were generally considered for IB. The results also indicated that in interstitial brachytherapy, better rectal sparing was achieved by including the tandem for treatment delivery. PACS numbers: 87.53.Bn, 87.53.Jw, 87.55.D‐, 87.55.dk John Wiley and Sons Inc. 2014-05-08 /pmc/articles/PMC5711042/ /pubmed/24892331 http://dx.doi.org/10.1120/jacmp.v15i3.4509 Text en © 2014 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Bansal, Anil K. Semwal, Manoj K. Sharma, Daya N. Thulkar, Sanjay Julka, Pramod K. Rath, Goura K. A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix |
title | A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix |
title_full | A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix |
title_fullStr | A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix |
title_full_unstemmed | A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix |
title_short | A patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix |
title_sort | patient‐based dosimetric study of intracavitary and interstitial brachytherapy in advanced stage carcinoma of the cervix |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711042/ https://www.ncbi.nlm.nih.gov/pubmed/24892331 http://dx.doi.org/10.1120/jacmp.v15i3.4509 |
work_keys_str_mv | AT bansalanilk apatientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT semwalmanojk apatientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT sharmadayan apatientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT thulkarsanjay apatientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT julkapramodk apatientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT rathgourak apatientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT bansalanilk patientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT semwalmanojk patientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT sharmadayan patientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT thulkarsanjay patientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT julkapramodk patientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix AT rathgourak patientbaseddosimetricstudyofintracavitaryandinterstitialbrachytherapyinadvancedstagecarcinomaofthecervix |